While Kimberly-Clark faces short-term hurdles from a dynamic retail landscape and high promotional costs, its strategic initiatives set a foundation for growth.

WDAY reports strong third-quarter fiscal 2025 results, backed by growing demand for human capital and financial management solutions across several sectors.

French asset manager Amundi holds a 1.3% stake in UniCredit on behalf of its clients, Europe's biggest fund management company said in reply to a Reuters query.

Arcutis Biotherapeutics, Inc. (ARQT) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ARQT's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

From a technical perspective, Mister Car Wash, Inc. (MCW) is looking like an interesting pick, as it just reached a key level of support. MCW's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

From a technical perspective, Arteris, Inc. (AIP) is looking like an interesting pick, as it just reached a key level of support. AIP's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Proto Labs, Inc. (PRLB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, PRLB's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

The mean of analysts' price targets for Abercrombie (ANF) points to a 26.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 60.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for FuelCell Energy (FCEL) points to a 176.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.